Stockreport

Biotech investor Cormorant secures $150M for another SPAC deal [Yahoo! Finance]

BridgeBio Oncology Therapeutics, Inc.  (BBOT) 
PDF A blank-check entity formed by biotechnology investor Cormorant Asset Management has raised $150 million in an initial public offering meant to support a future merger [Read more]